{"id":"https://openalex.org/W1981125406","doi":"https://doi.org/10.4103/0301-4738.27948","title":"The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis","display_name":"The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W1981125406","doi":"https://doi.org/10.4103/0301-4738.27948","mag":"1981125406","pmid":"https://pubmed.ncbi.nlm.nih.gov/17090875"},"language":"en","primary_location":{"id":"doi:10.4103/0301-4738.27948","doi":"https://doi.org/10.4103/0301-4738.27948","is_oa":true,"landing_page_url":"https://doi.org/10.4103/0301-4738.27948","pdf_url":null,"source":{"id":"https://openalex.org/S191336577","display_name":"Indian Journal of Ophthalmology","issn_l":"0301-4738","issn":["0301-4738","1998-3689"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Indian Journal of Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.4103/0301-4738.27948","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030678173","display_name":"Peykan T\u00fcrk\u00e7\u00fco\u011flu","orcid":"https://orcid.org/0000-0002-9750-6213","observed_orcids":["https://orcid.org/0000-0002-9750-6213"]},"institutions":[{"id":"https://openalex.org/I143396566","display_name":"F\u0131rat University","ror":"https://ror.org/05teb7b63","country_code":"TR","type":"education","lineage":["https://openalex.org/I143396566"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Peykan T\u00fcrk\u00e7\u00fcoglu","raw_affiliation_strings":["Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey","to Peykan T\u00fcrk\u00e7\u00fcoglu, Instructor of Ophthalmology, Firat University School of Medicine, Department of Ophthalmology, Elazig, Turkey. E-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey","institution_ids":["https://openalex.org/I143396566"]},{"raw_affiliation_string":"to Peykan T\u00fcrk\u00e7\u00fcoglu, Instructor of Ophthalmology, Firat University School of Medicine, Department of Ophthalmology, Elazig, Turkey. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I143396566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113483586","display_name":"Tamer Dem\u0131r","orcid":"https://orcid.org/0000-0001-8998-5835","observed_orcids":["https://orcid.org/0000-0001-8998-5835"]},"institutions":[{"id":"https://openalex.org/I143396566","display_name":"F\u0131rat University","ror":"https://ror.org/05teb7b63","country_code":"TR","type":"education","lineage":["https://openalex.org/I143396566"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Tamer Demir","raw_affiliation_strings":["Firat University School of Medicine, Department of Ophthalmology, Elazig, Turkey","Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Firat University School of Medicine, Department of Ophthalmology, Elazig, Turkey","institution_ids":["https://openalex.org/I143396566"]},{"raw_affiliation_string":"Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey","institution_ids":["https://openalex.org/I143396566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068205185","display_name":"Ahmet G\u00f6dekmerdan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143396566","display_name":"F\u0131rat University","ror":"https://ror.org/05teb7b63","country_code":"TR","type":"education","lineage":["https://openalex.org/I143396566"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ahmet G\u00f6dekmerdan","raw_affiliation_strings":["Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey","institution_ids":["https://openalex.org/I143396566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006588049","display_name":"Mehmet Balbaba","orcid":"https://orcid.org/0000-0003-1337-459X","observed_orcids":["https://orcid.org/0000-0003-1337-459X"]},"institutions":[{"id":"https://openalex.org/I143396566","display_name":"F\u0131rat University","ror":"https://ror.org/05teb7b63","country_code":"TR","type":"education","lineage":["https://openalex.org/I143396566"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Mehmet Balbaba","raw_affiliation_strings":["Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey","institution_ids":["https://openalex.org/I143396566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009935624","display_name":"Fulya \u0130lhan","orcid":"https://orcid.org/0000-0001-7790-1358","observed_orcids":["https://orcid.org/0000-0001-7790-1358"]},"institutions":[{"id":"https://openalex.org/I143396566","display_name":"F\u0131rat University","ror":"https://ror.org/05teb7b63","country_code":"TR","type":"education","lineage":["https://openalex.org/I143396566"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Fulya Ilhan","raw_affiliation_strings":["Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey","institution_ids":["https://openalex.org/I143396566"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079081230","display_name":"Nesrin Demir","orcid":"https://orcid.org/0000-0003-3658-0185","observed_orcids":["https://orcid.org/0000-0003-3658-0185"]},"institutions":[{"id":"https://openalex.org/I143396566","display_name":"F\u0131rat University","ror":"https://ror.org/05teb7b63","country_code":"TR","type":"education","lineage":["https://openalex.org/I143396566"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Nesrin Demir","raw_affiliation_strings":["Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Firat University School of Medicine, Department of Ophthalmology (TD,MB,PT) and Department of Immunology (AG,FI,ND), Elazig, Turkey","institution_ids":["https://openalex.org/I143396566"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030678173"],"corresponding_institution_ids":["https://openalex.org/I143396566"],"apc_list":null,"apc_paid":null,"fwci":1.4219,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.82629174,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"54","issue":"4","first_page":"241","last_page":"241"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/experimental-autoimmune-uveitis","display_name":"experimental autoimmune uveitis","score":0.9200000166893005},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/recombinant-il-10","display_name":"recombinant IL-10","score":0.984000027179718},{"id":"https://openalex.org/keywords/vitreous-cytokines","display_name":"vitreous cytokines","score":0.9909999966621399},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.7279999852180481},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.949999988079071},{"id":"https://openalex.org/keywords/interleukin-1","display_name":"interleukin-1","score":0.984000027179718},{"id":"https://openalex.org/keywords/retinal-s-antigen","display_name":"retinal S-antigen","score":0.8019999861717224},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.6620000004768372},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9517847299575806},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.8956469297409058},{"id":"https://openalex.org/C2776194053","wikidata":"https://www.wikidata.org/wiki/Q280027","display_name":"Uveitis","level":2,"score":0.7413133382797241},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.6029117107391357},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5113174915313721},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.4845651686191559},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.437531977891922},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007274","descriptor_name":"Injections, Intraperitoneal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011917","descriptor_name":"Rats, Inbred Lew","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014605","descriptor_name":"Uveitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014605","descriptor_name":"Uveitis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014605","descriptor_name":"Uveitis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014822","descriptor_name":"Vitreous Body","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014822","descriptor_name":"Vitreous Body","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016753","descriptor_name":"Interleukin-10","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016753","descriptor_name":"Interleukin-10","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019393","descriptor_name":"Arrestin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.4103/0301-4738.27948","doi":"https://doi.org/10.4103/0301-4738.27948","is_oa":true,"landing_page_url":"https://doi.org/10.4103/0301-4738.27948","pdf_url":null,"source":{"id":"https://openalex.org/S191336577","display_name":"Indian Journal of Ophthalmology","issn_l":"0301-4738","issn":["0301-4738","1998-3689"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Indian Journal of Ophthalmology","raw_type":"journal-article"},{"id":"pmid:17090875","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17090875","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Indian journal of ophthalmology","raw_type":"Journal Article"},{"id":"pmh:f8a51684-44b8-4b4e-82f3-5c1bea82e1cd","doi":null,"is_oa":false,"landing_page_url":"https://avesis.comu.edu.tr/publication/details/f8a51684-44b8-4b4e-82f3-5c1bea82e1cd/oai","pdf_url":null,"source":{"id":"https://openalex.org/S7407055198","display_name":"\u00c7anakkale Onsekiz Mart University AVESIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:openaccess.firat.edu.tr:11508/42021","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11508/42021","pdf_url":null,"source":{"id":"https://openalex.org/S4377196733","display_name":"DSpace - FIRAT (F\u0131rat University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I143396566","host_organization_name":"F\u0131rat University","host_organization_lineage":["https://openalex.org/I143396566"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.4103/0301-4738.27948","doi":"https://doi.org/10.4103/0301-4738.27948","is_oa":true,"landing_page_url":"https://doi.org/10.4103/0301-4738.27948","pdf_url":null,"source":{"id":"https://openalex.org/S191336577","display_name":"Indian Journal of Ophthalmology","issn_l":"0301-4738","issn":["0301-4738","1998-3689"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Indian Journal of Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2591979429","https://openalex.org/W2027345885","https://openalex.org/W2088203172","https://openalex.org/W2394864863","https://openalex.org/W2089338444","https://openalex.org/W2347254800","https://openalex.org/W2052516431","https://openalex.org/W2360707796","https://openalex.org/W2354892053","https://openalex.org/W2153565262"],"abstract_inverted_index":{"BACKGROUND:":[0],"To":[1],"identify":[2],"the":[3,31,34,45,70,78,86,95,122,126,147,160,167,182,188,197,229],"effect":[4],"of":[5,27,50,102,125],"infliximab,":[6],"cyclosporine":[7,56,62,189],"A":[8,57,63,190],"and":[9,66,74,91,109,114,132,139,154,179,194,218,225],"recombinant":[10,96,103,198,226,236],"IL-10":[11,97,104,199,227],"in":[12,61,69,181,187,196,209,241],"experimental":[13,243],"autoimmune":[14],"uveitis.":[15],"MATERIALS":[16],"AND":[17],"METHODS:":[18],"Sixty":[19],"male":[20],"rats":[21,129],"were":[22,37,105,130,141,156],"assigned":[23],"to":[24,177,211],"five":[25],"groups":[26,32],"12":[28],"each.":[29],"All":[30],"(except":[33],"control":[35,75,168],"group)":[36],"administered":[38,84],"30":[39],"microg":[40],"retinal-S":[41,118],"antigen":[42,119],"intraperitoneally.":[43],"On":[44,121],"14th":[46],"day,":[47],"after":[48,117],"confirmation":[49],"uveitis":[51],"with":[52,143,166,175],"histopathological":[53],"study,":[54,127],"daily":[55],"injection":[58],"was":[59,83,171],"given":[60,106],"treatment":[64,73,80,98,148,163,184,191,200],"group":[65],"physiological":[67],"serum":[68],"uveitis-induced":[71,161],"placebo":[72,162],"groups.":[76],"In":[77,94,146],"infliximab":[79,82,183,224],"group,":[81,99,169],"on":[85,214],"14th,":[87],"15th,":[88],"17th,":[89],"19th":[90],"21st":[92,123],"days.":[93],"three":[100],"doses":[101],"four":[107],"hours":[108,112,116],"a":[110,249],"half":[111],"before":[113],"eight":[115],"administration.":[120],"day":[124],"all":[128],"sacrificed":[131],"vitreous":[133,215,230],"cytokine":[134,150],"levels":[135,151],"(IL-1,":[136,152],"IL-6,":[137,216],"IL-8":[138,180,186,195,217],"TNF-alpha)":[140,155],"studied":[142],"ELISA.":[144],"RESULTS:":[145],"groups,":[149],"IL-6":[153,193],"significantly":[157,207],"lower":[158],"than":[159],"group.":[164,201],"Compared":[165],"there":[170],"no":[172],"significant":[173],"difference":[174],"respect":[176,210],"TNF-alpha":[178,219],"group;":[185,192],"The":[202],"drugs":[203],"used":[204],"did":[205],"not":[206],"differ":[208],"their":[212],"effects":[213],"levels.":[220,232],"CONCLUSION:":[221],"Cyclosporine":[222],"A,":[223],"reduce":[228],"cytokines":[231],"Among":[233],"these":[234],"drugs,":[235],"IL-10,":[237],"which":[238],"is":[239],"still":[240],"its":[242],"phase,":[244],"might":[245],"be":[246],"considered":[247],"as":[248],"new":[250],"therapeutic":[251],"agent.":[252]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}